Session Type
Meeting
Search Results for Cancer
Abstract Number: 86
SHM Converge 2024
Background: The number of elderly stage IV cancer patients is increasing every year. Various factors need to be considered for systemic cancer treatment in older patients. This study was conducted to examine the difference in clinical features and overall survival between the group that received the best supportive care and the group that received active […]
Abstract Number: 220
SHM Converge 2024
Background: Patients with cancer diagnoses are known to have the highest likelihood of readmission to the hospital based on nationally available data. Reducing readmissions to the hospital has remained a national priority in healthcare quality, however it can be challenging to identify patients who are at highest risk for readmission to the hospital. Currently, our […]
Abstract Number: 230
SHM Converge 2024
Background: Tobacco use is the most widespread preventable cause of cancer and is linked to 30% of cancer-related deaths.(1) Many smokers want to quit but are unsuccessful; tools such as nicotine replacement therapy (NRT) products can increase quit rates by 50-60%.(2) While smoking cessation is the ideal way to combat tobacco-related diseases, screening for diseases […]
Abstract Number: 456
SHM Converge 2024
Background: Observations units commonly serve as an intermediate stage between the emergency department and inpatient hospitalization where patients of appropriate acuity are managed, however many observation units exist serving diverse patient populations ranging from peripartum or post-op surgical. Patients in observation units typically have lower-acuity health concerns and have an average length of stay of […]
Abstract Number: 466
SHM Converge 2024
Case Presentation: A 91-year-old male with a known history of benign prostatic hyperplasia (BPH), diastolic heart failure, pulmonary embolism, hypertension, and previous extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (E. coli) urinary tract infection (UTI) presented with encephalopathy. He was not tachypneic nor tachycardic, but his bicarbonate was low at less than 8, and his lactic acid […]
Abstract Number: 469
SHM Converge 2024
Case Presentation: A 56-year-old female with invasive lobular carcinoma of the breast, diagnosed 8 years prior and currently on neratinib and capecitabine, presented to her oncologist endorsing abdominal pain, vomiting, nausea, and loss of appetite for several days. Despite anti-emetic therapy, symptoms persisted, and she lost weight over the next 6 weeks. Computed Tomography (CT) […]
Abstract Number: 529
SHM Converge 2024
Case Presentation: An 86-year-old male with a past medical history of bladder cancer, status post Bacillus Calmette-Guerin (BCG) therapy 12 months prior, presented to the ED with three months of progressively worsening back pain and weight loss. He denied cough, fever, night sweats, dysuria, recent travel, history of farming, exposure to cattle, or consumption of […]
Abstract Number: 532
SHM Converge 2024
Case Presentation: A 27-year-old man without significant medical history presented with constipation and weight loss of 25 pounds in 2 months. A digital rectal examination revealed a fungating mass in the rectum. CT abdomen/pelvis showed the presence of a large intraluminal rectal mass measuring 6.8 X 5.8 X 6.3 cm with no evidence of metastasis. […]
Abstract Number: 619
SHM Converge 2024
Case Presentation: A 75-year-old male with atrial fibrillation on apixaban and eradicated HCV presented to the Emergency Department one day after a syncopal episode with right upper quadrant abdominal pain. On initial presentation, he was hemodynamically unstable with hypotension and atrial fibrillation with rapid ventricular response. His vital signs normalized after 2 liters of intravenous […]
Abstract Number: 676
SHM Converge 2024
Case Presentation: In September 2021, a 53-year-old male with a BMI of 30.91 and no history of alcohol use was diagnosed with advanced prostate cancer, indicated by a PSA level of 111. A transrectal ultrasound-guided prostate biopsy revealed Gleason score 4+5 prostate adenocarcinoma. In February 2022, the patient initiated treatment with Androgen Deprivation Therapy (ADT) […]